MLECMLECHealthcare · Biotechnology

MLEC Stock Forecast: Moolec Science SA Price Predictions for 2026-2027

Last close, 21 Aug 2026
$7.21
+3.59% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 3 of 100 as at 21 Aug 2026 — in the weakest quartile.

Market cap
$5.1M
Ticker Nerd rank
3 / 100
Median analyst target
Analysts covering
1
Total return, dividends reinvested
1W
+0.1%
1M
−14.7%
YTD
+88.5%
1Y
−74.7%
From 52W high
−74.7%
From 52W low
+113.6%
$3
$29
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

MLEC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Moolec Science SA on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Aug 2026
3 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
96
Volatility
34
Momentum
25
Revisions
25
Accruals
8
Growth
3
Issuance
1
Quality
1
Value
0

Size (96): Smaller than most of the companies we track.

Value (0): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MLEC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MLEC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15$20$25$30Oct 25Jan 26Apr 26Jul 26MLEC

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Recent analyst actionsNewest first
DateFirmActionRatingTarget
30 Jan 2024Maxim GroupInitiatesBuy$6.00
22 Nov 2022Cantor FitzgeraldUpgradeOverweight
20 Oct 2022HC Wainwright & Co.MaintainsBuy
26 Sept 2022WedbushMaintainsOutperform
7 Sept 2022Capital OneInitiatesOverweight

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MLEC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

MLEC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Moolec Science SA (MLEC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.0×

Cheaper than 76% of US stocks

Price / sales
0.0×

Cheaper than 99% of US stocks

Price / book
10.0×

Cheaper than 11% of US stocks

EV / EBITDA
−3.1×

Cheaper than 74% of US stocks

Growth & margins
Revenue growth (YoY)
69.7%

Higher than 90% of US stocks

Earnings growth (YoY)
948.3%

Higher than 97% of US stocks

Gross margin
−25.5%

Higher than 3% of US stocks

Operating margin
−39.5%

Higher than 18% of US stocks

Net margin
37.7%

Higher than 93% of US stocks

Returns & dividend
Return on equity
55.8%

Higher than 94% of US stocks

Return on assets
−22.6%

Higher than 18% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

MLEC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
MLECMoolec Science SA$5.1M
3
BCABBioAtla, Inc.$5.3M
26
LABTLakewood-Amedex Biotherapeutics, Inc.$5.3M
25
APVOAptevo Therapeutics, Inc.$4.8M
26
JUNSJupiter Neurosciences, Inc.$4.8M
11
GOVXGeoVax Labs, Inc.$4.8M
29
VIVSVivoSim Labs, Inc.$4.7M
30

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Moolec Science SA — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Frequently asked questions about MLEC stock

Is MLEC stock a buy right now?

Of the 1 analysts covering Moolec Science SA, 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Moolec Science SA 3 out of 100 across roughly 4,600 US stocks as at 21 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MLEC?

As at 21 Aug 2026, Moolec Science SA ranks 3 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (96 of 100).

What is the MLEC stock forecast for 2030?

No analyst covering Moolec Science SA publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MLEC are extrapolating price history, which says nothing about the business.

How has MLEC stock performed over the past year?

Moolec Science SA returned -74.7% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Moolec Science SA do?

Moolec Science SA is a science-based food ingredient company specializing in molecular farming technology to produce animal proteins, nutritional oils, and functional ingredients directly in plants and microbes. It develops innovative products such as Piggy Sooy, a soybean engineered to express porcine hemeproteins for enhanced taste, texture, and nutrition, and GLASO, a safflower oil enriched with gamma-linolenic acid for applications in pet food, human nutrition, and supplements.

Company

About Moolec Science SA.

Moolec Science SA is a science-based food ingredient company specializing in molecular farming technology to produce animal proteins, nutritional oils, and functional ingredients directly in plants and microbes. It develops innovative products such as Piggy Sooy, a soybean engineered to express porcine hemeproteins for enhanced taste, texture, and nutrition, and GLASO, a safflower oil enriched with gamma-linolenic acid for applications in pet food, human nutrition, and supplements. The company integrates molecular farming with precision fermentation to create sustainable solutions for food, pet food, animal feed, dietary supplements, and regenerative agriculture inputs. Through platforms like Mycofood for fungal-based proteins and ag-biologicals from associated brands, Moolec Science SA addresses needs in the food-tech and life sciences sectors. Operating across the United States, Europe, and South America, it supports the global food system with scalable, bio-based ingredients that combine crop efficiency with animal-like functionality. Founded in 2020 and headquartered in Luxembourg, Moolec Science SA drives advancements in sustainable ingredient production.

CEO Mr. Gaston Paladini M.B.A. · 52 employees · Cayman Islands · https://www.moolecscience.com